Reducing Piperacillin and Tazobactam Use for Pediatric Perforated Appendicitis
Talal B Seddik1, Lauren A Rabsatt2, Claudia Mueller3
1Pediatric Infectious Diseases, Stanford University School of Medicine, Stanford, California.
Insights
An intervention successfully reduced piperacillin and tazobactam (PT) use in pediatric perforated appendicitis. This change did not affect clinical outcomes, demonstrating a safe approach to antibiotic stewardship.
Area of Science:
- Pediatric Surgery
- Infectious Diseases
- Antibiotic Stewardship
Background:
- Perforated appendicitis often leads to infectious complications, but optimal antibiotic selection remains debated.
- Piperacillin and tazobactam (PT) is a broad-spectrum antibiotic frequently used in such cases.
- There is a need to evaluate strategies for reducing PT use while maintaining patient safety.
Purpose of the Study:
- To assess the effectiveness and safety of an intervention aimed at decreasing piperacillin and tazobactam (PT) use in pediatric acute perforated appendicitis.
- To evaluate the impact of provider education and electronic order modification on PT utilization.
Main Methods:
- A single-center, retrospective cohort study included children (≤18 years) undergoing appendectomy for perforated appendicitis.
- An intervention involved provider education followed by electronic antibiotic order modification to default to ceftriaxone and metronidazole.
- Preintervention and postintervention PT exposure and clinical outcomes were compared.
Main Results:
- Piperacillin and tazobactam (PT) exposure decreased significantly from 78% to 18% post-intervention (P < 0.001).
- Use of PT for at least half of intravenous antibiotic days also dropped significantly from 78% to 13% (P < 0.001).
- No significant differences were observed in antibiotic duration, length of stay, surgical site infection rates, or 30-day readmission rates.
Conclusions:
- Provider education and electronic antibiotic order changes effectively reduced piperacillin and tazobactam (PT) use in pediatric perforated appendicitis.
- The intervention was safe, as evidenced by the lack of negative impact on key clinical outcomes.
- This study supports targeted interventions for antibiotic stewardship in pediatric surgical infections.
Background:
Although perforated appendicitis is associated with infectious complications, the choice of antibiotic therapy is controversial. We assess the effectiveness and safety of an intervention to reduce piperacillin and tazobactam (PT) use for pediatric acute perforated appendicitis.
Methods:
This is a single-center, retrospective cohort study of children 18 y of age or younger who underwent primary appendectomy for perforated appendicitis between January 01, 2016 and June 30, 2019. An intervention to decrease PT use was implemented: the first phase was provider education (April 19, 2017) and the second phase was modification of electronic antibiotic orders to default to ceftriaxone and metronidazole (July 06, 2017). Preintervention and postintervention PT exposure, use of PT ≥ half of intravenous antibiotic days, and clinical outcomes were compared.
Results:
Forty children before and 109 after intervention were included and had similar baseline characteristics. PT exposure was 31 of 40 (78%) and 20 of 109 (18%) (P < 0.001), and use ≥ half of intravenous antibiotic days was 31 of 40 (78%) and 14 of 109 (13%) (P < 0.001), in the preintervention and postintervention groups, respectively. There was no significant difference in mean duration of antibiotic therapy (10.8 versus 9.8 d), mean length of stay (6.2 versus 6.5 d), rate of surgical site infection (10% versus 11%), or rate of 30-d readmission and emergency department visit (20% versus 20%) between the preintervention and postintervention periods, respectively.
Conclusions:
Provider education and modification of electronic antibiotic orders safely reduced the use of PT for pediatric perforated appendicitis.
More Related Videos
03:42Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Acute Pyelonephritis II: Diagnostic Studies and Management
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Pericarditis III: Medical Management
